HAYWARD, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Solta Medical,
Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics
market, today announced that Stephen J.
Fanning, Chairman, President and Chief Executive Officer of
Solta, will be participating in two upcoming investor
conferences.
|
Conference:
|
Collins Stewart Health Care
Event
|
|
|
Date:
|
Wednesday, August 11
|
|
|
Location:
|
New York City, NY
|
|
|
|
|
|
Conference:
|
30th Annual Canaccord Genuity
Growth Conference
|
|
|
Date:
|
Thursday, August 12
|
|
|
Time:
|
10:00 am ET
|
|
|
Location:
|
Boston, MA.
|
|
|
|
Attendance at these conferences is by invitation only.
A live audio webcast of the Company's presentation at the
Canaccord Genuity conference may be accessed at the Investor
Relations section of the Company's website at www.solta.com. An
archived replay will be available for 30 days following each event
at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a range of
skin issues under the industry's three premier brands: Thermage(R),
Fraxel(R) and Isolaz(R). Thermage is an innovative, non-invasive
radiofrequency procedure for tightening and contouring skin. As the
leader in fractional laser technology, Fraxel delivers minimally
invasive clinical solutions to resurface aging and sun damaged
skin. Isolaz is the only laser or light based system indicated for
the treatment of inflammatory acne, comedonal acne, pustular acne,
and mild-to-moderate inflammatory acne. Since 2002, approximately
one million Thermage, Fraxel and Isolaz procedures have been
performed in over 100 countries. For more information about Solta
Medical, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.
Copyright g. 4 PR Newswire